Glenn Greenberg
Brave Warrior Advisors
Brave Warrior Advisors 13F holdings
Glenn Greenberg's Portfolio
- Portfolio value:
- $3.14B≈
- # of securities:
- 23
- Reported for:
- 31 Dec 2021 (Q4)
- Latest filing date:
- 14 Feb 2022
What stocks did Glenn Greenberg own in 2021 Q4?
What was Glenn Greenberg's 2021 Q4 portfolio?
Brave Warrior Advisors has disclosed a total of 23 security holdings in their (2021 Q4) SEC 13F filing(s) with portfolio value of $3,138,076,000.
Brave Warrior Advisors's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Glenn Greenberg's original 13F reports (2021 Q4) are the official SEC institutional disclosure documents covering all reported equity positions.
23 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Elevance Health Inc
|
20.17%
|
1,365,785
|
$463.54
|
-18.05%($379.86)
|
$633,096,000
|
2019 Q3
|
≈ 2.50 years
|
Common Stock
|
-0.40% (-5.48K)
|
-0.09%
|
|
|
|
Fidelity National Financial Inc
|
14.37%
|
8,639,966
|
$52.18
|
-1.38%($51.46)
|
$450,833,000
|
2021 Q2
|
≈ 0.75 years
|
Common Stock
|
-1.73% (-152.44K)
|
-0.28%
|
|
|
|
Primerica Inc
|
9.42%
|
1,929,120
|
$153.27
|
+108.81%($320.05)
|
$295,676,000
|
2013 Q2 or earlier
|
≈ 8.75+ years
|
Common Stock
|
+1.45% (+27.59K)
|
+0.13%
|
|
|
|
Valvoline Inc
|
8.91%
|
7,495,661
|
$37.29
|
+4.08%($38.81)
|
$279,513,000
|
2021 Q1
|
≈ 1.00 year
|
Common Stock
|
-1.61% (-122.35K)
|
-0.16%
|
|
|
|
APOLLO GLOBAL MANAGEMENT - A
|
7.72%
|
3,346,129
|
$72.43
|
|
$242,360,000
|
2021 Q3
|
≈ 0.50 years
|
Partnership Shares
|
+33.47% (+839.09K)
|
+1.94%
|
|
|
|
JPMorgan Chase & Co
|
7.54%
|
1,494,992
|
$158.35
|
+122.34%($352.07)
|
$236,732,000
|
2014 Q3
|
≈ 7.50 years
|
Common Stock
|
-10.59% (-177.13K)
|
-0.98%
|
|
|
|
Progressive Corp
|
7.34%
|
2,242,456
|
$102.65
|
+104.62%($210.04)
|
$230,188,000
|
2019 Q4
|
≈ 2.25 years
|
Common Stock
|
-1.76% (-40.26K)
|
-0.14%
|
|
|
|
Raymond James Financial Inc
|
7.14%
|
2,232,515
|
$100.40
|
+76.23%($176.94)
|
$224,145,000
|
2018 Q3
|
≈ 3.50 years
|
Common Stock
|
-1.59% (-36K)
|
-0.13%
|
|
|
|
Berkshire Hathaway Inc
|
6.40%
|
671,870
|
$299.00
|
+71.37%($512.40)
|
$200,889,000
|
2019 Q2
|
≈ 2.75 years
|
Common Stock
|
-1.98% (-13.59K)
|
-0.14%
|
|
|
|
HCA Healthcare, Inc
|
4.98%
|
608,397
|
$256.92
|
+56.99%($403.35)
|
$156,309,000
|
2020 Q1
|
≈ 2.00 years
|
Common Stock
|
-1.77% (-10.99K)
|
-0.1%
|
|
Completely sold out
2 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Charles Schwab Corp
|
-707,943
|
-1.81%
|
2013 Q2 or earlier
|
≈ 8.50+ years
|
|
|
|
Meta Platforms Inc
|
-1,246
|
-0.01%
|
2020 Q1
|
≈ 1.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.